JPMorgan Chase & Co’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1
| Closed | -$3 | – | 6453 |
|
|
2024
Q3 | $3 | Sell |
1
-5
| -83% | -$15 | ﹤0.01% | 6273 |
|
|
2024
Q2 | $21 | Sell |
6
-1
| -14% | -$4 | ﹤0.01% | 6135 |
|
|
2024
Q1 | $41 | Buy |
7
+4
| +133% | +$23 | ﹤0.01% | 6059 |
|
|
2023
Q4 | $45 | Buy |
3
+1
| +50% | +$15 | ﹤0.01% | 6179 |
|
|
2023
Q3 | $15 | Buy |
+2
| New | +$15 | ﹤0.01% | 6270 |
|
|
2022
Q2 | – | Sell |
-40
| Closed | -$1K | – | 5769 |
|
|
2022
Q1 | $1K | Buy |
+40
| New | +$1K | ﹤0.01% | 5648 |
|